Defect in Bernard soulier lies in –
So the core concept here is platelet adhesion and the glycoproteins involved. Bernard-Soulier is caused by a defect in the GP Ib-IX-V complex, which is crucial for binding to von Willebrand factor. That makes sense because the GP Ib complex is the main receptor on platelets for vWF, which helps in adhesion to the vessel wall during hemostasis.
Now, the correct answer would be the one that mentions the GP Ib-IX-V complex. Let me check the options. The user didn't list the options, but common distractors might include other platelet receptors or factors. For example, maybe GP IIb/IIIa (which is involved in aggregation), or maybe something related to von Willebrand factor itself, or perhaps other glycoproteins like GP Ia.
Why are the other options wrong? If one option says GP IIb/IIIa, that's incorrect because that's involved in platelet aggregation via fibrinogen binding. Another option might be the von Willebrand factor, but Bernard-Soulier is a receptor defect, not a deficiency of vWF. Another option could be a clotting factor, which is unrelated to platelet function.
Clinical pearl: Remember that Bernard-Soulier leads to large platelets and a bleeding diathesis, and the key defect is in the GP Ib complex. Also, it's autosomal recessive. So the high-yield fact is the specific glycoprotein complex involved and its role in adhesion.
Putting it all together, the correct answer is the defect in GP Ib-IX-V complex. The explanation should highlight the role of this complex in vWF binding and how its defect leads to impaired adhesion. The wrong options are ruled out by their roles in other processes like aggregation or being different glycoproteins.
**Core Concept**
Bernard-Soulier syndrome is a rare autosomal recessive platelet disorder caused by mutations in the **GP1BA**, **GP1BB**, or **GP9** genes, which encode the **GP Ib-IX-V complex**. This complex is critical for platelet adhesion via binding to von Willebrand factor (vWF) in damaged endothelium.
**Why the Correct Answer is Right**
The defect in Bernard-Soulier lies in the **GP Ib-IX-V receptor complex** on platelet surfaces. This receptor binds vWF, initiating platelet adhesion to exposed subendothelial collagen at injury sites. Mutations in the genes encoding this complex lead to dysfunctional adhesion, resulting in thrombocytopenia, large platelets, and mucocutaneous bleeding. The absence of functional GP Ib-IX-V prevents vWF from anchoring platelets, disrupting primary hemostasis.
**Why Each Wrong Option is Incorrect**
**Option A:** *GP IIb/IIIa deficiency* (e.g., Glanzmann thrombasthenia) causes aggregation defects,